Marco R. de Groot

2.2k citations

38 papers · 1.7k · 1 hit paper · h-index 18

Impact in

Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in

Hematology 17
- Hematopoietic Stem Cell Transplantation 12
- Acute Myeloid Leukemia Research 7
Oncology 9
- Cancer Cells and Metastasis 5

Co-authors: Leon W.M.M. Terstappen (5 shared papers)WALTER J.B. MASTBOOM (3 shared papers)Arjan G.J. Tibbe (3 shared papers)István Vermes (2 shared papers)François‐Clément Bidard (2 shared papers)Jean‐Yves Pierga (2 shared papers)Bas Franken (2 shared papers)Job A.M. van der Palen (1 shared paper)
Journals: Blood (3 papers)British Journal of Haematology (3 papers)Bone Marrow Transplantation (2 papers)Clinical Infectious Diseases (2 papers)International Journal of Oncology (2 papers)
Partner nations: Netherlands France Belgium

In The Last Decade

Marco R. de Groot

38 papers receiving 1.6k citations

Marco R. de Groot's Hit Papers

align trajectories log scale

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia 2022 · 181 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2022 New England Journal of Medicine

Peers

Countries citing papers authored by Marco R. de Groot

Since Specialization

Citations

This map shows the geographic impact of Marco R. de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco R. de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco R. de Groot more than expected).

Fields of papers citing papers by Marco R. de Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco R. de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco R. de Groot. The network helps show where Marco R. de Groot may publish in the future.

Co-authors

The 25 scholars most cited alongside Marco R. de Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marco R. de Groot Line = papers co-authored together Marco R. de Groot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer Clinical Cancer Research ·Wolfgang Janni, Brigitte Kathrin Rack, Leon W.M.M. Terstappen, Jean‐Yves Pierga, Florin‐Andrei Taran, Tanja Natascha Fehm, Carolyn S. Hall, Marco R. de Groot	2016	303
2	A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma Cancer ·Christian Wülfing, Jean‐Pascal Machiels, Dirk J. Richel, Marc‐Oliver Grimm, Uwe Treiber, Marco R. de Groot, Philippe Beuzeboc, Roma Parikh	2009	186
3	Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia New England Journal of Medicine ·Régis Peffault de Latour, Austin Gladston Kulasekararaj, Simona Iacobelli, Sofie Rosanne Terwel, Riley Cook, Morag Griffin, Constantijn J.M. Halkes, Christian Récher Hit paper breakdown →	2022	181
4	Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer Breast Cancer Research ·Bas Franken, Marco R. de Groot, WALTER J.B. MASTBOOM, István Vermes, Job A.M. van der Palen, Arjan G.J. Tibbe, Leon W.M.M. Terstappen	2012	159
5	Importance of circulating tumor cells in newly diagnosed colorectal cancer International Journal of Oncology ·Guus van Dalum, Gerrit-Jan Stam, Loes F.A. Scholten, WALTER J.B. MASTBOOM, István Vermes, Arjan G.J. Tibbe, Marco R. de Groot, Leon W.M.M. Terstappen	2015	97
6	Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial Blood Advances ·Annoek E. C. Broers, Cornelis N. de Jong, Katerina Bakunina, Mette D. Hazenberg, Marinus van Marwijk Kooy, Marco R. de Groot, Michel van Gelder, Jurgen H. E. Kuball	2022	87
7	Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer PLoS ONE ·Sjoerd T. Ligthart, Frank A. W. Coumans, François‐Clément Bidard, Lieke H. J. Simkens, Cornelis J.A. Punt, Marco R. de Groot, Gerhardt Attard, Johann Sebastian De Bono	2013	86
8	High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis Journal of Hepatology ·Elske Hoornenborg, Liza Coyer, Anders C. Boyd, Roel Achterbergh, Maarten F. Schim van der Loeff, Sylvia Maria Bruisten, Henry J.C. de Vries, Jelle Koopsen	2019	59
9	High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands Clinical Infectious Diseases ·Anne Boerekamps, Astrid M. Newsum, Colette Smit, Joop E. Arends, Clemens Richter, PETER C. REISS, Bart J. A. Rijnders, Kees Brinkman	2017	57
10	Circulating tumor cells before and during follow-up after breast cancer surgery International Journal of Oncology ·Guus van Dalum, GERT JAN VAN DER STAM, Arjan G.J. Tibbe, Bas Franken, WALTER J.B. MASTBOOM, IVAN VERMES, Marco R. de Groot, Leon W.M.M. Terstappen	2014	55
11	Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome Journal of the American College of Cardiology ·Tjerk S.J. Opstal, Aernoud T.L. Fiolet, Amber van Broekhoven, Arend Mosterd, John W. Eikelboom, Stefan Mark Nidorf, Peter Lindsay Thompson, Michiel Duyvendak	2021	47
12	Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen Clinical Cancer Research ·Frédéric Baron, Myriam Labopin, Annalisa Ruggeri, Jan J. Cornelissen, Ellen Meijer, Henrik Sengeloev, Dietger W. Niederwieser, Marco R. de Groot	2018	34
13	Effect of N ‐acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial British Journal of Haematology ·Joep W. R. Sins, Karin Fijnvandraat, Anita W. Rijneveld, Martine B. Boom, Jean‐Louis Kerkhoffs, Alfred H. van Meurs, Marco R. de Groot, Harriët Heijboer	2017	29
14	Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients Clinical Chemistry and Laboratory Medicine (CCLM) ·Herman Veenhof, Remco A. Koster, Jan‐Willem C. Alffenaar, Aad P. van den Berg, Marco R. de Groot, Erik Verschuuren, Stefan P. Berger, Stephan J. L. Bakker	2019	28
15	Vaccination responses and lymphocyte subsets after autologous stem cell transplantation Vaccine ·Ankie M.T. van der Velden, A.M.E. Claessen, Heleen van Velzen‐Blad, Marco R. de Groot, Mark H.H. Kramer, Douwe H. Biesma, Ger T. Rijkers	2007	26
16	Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations Frontiers in Immunology ·Kirsten Geneugelijk, Kirsten A. Thus, Hanneke W. M. van Deutekom, Jorg J. A. Calis, Eric Borst, Can Keşmir, Machteld Oudshoorn, Bronno van der Holt	2019	21
17	Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sara Hone Lopez, Gürsah Kats‐Ugurlu, Remco J. Renken, Henk J. Buikema, Marco R. de Groot, Marijn Caroline Visschedijk, Gerard Dijkstra, Mathilde Jalving	2021	20
18	Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration Clinical Infectious Diseases ·Erich S. Tusch, Lene Ryom, Annegret Pelchen–Matthews, Amanda Mocroft, Daniel Elbirt, Cristiana Oprea, Huldrych Fritz Günthard, Cornelia Staehelin	2024	19
19	Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients Haematologica ·Jaap Jan Zwaginga, Bronno van der Holt, Peter A. te Boekhorst, Bart J. Biemond, Mark‐David Levin, René van der Griend, Anneke Brand, Sonja Zweegman	2014	18
20	Identification of Two Distinct Mutations at the Same Nucleotide Position, Concomitantly with a Novel Polymorphism in the Vasopressin-Neurophysin II Gene (AVP-NP II) in Two Dutch Families with Familial Neurohypophyseal Diabetes Insipidus Clinical Chemistry ·André P. Abbes, Bennie Bruggeman, Erica L T van den Akker, Marco R. de Groot, Anton A M Franken, Valentijn R. Drexhage, Henk Engel	2000	17

About Marco R. de Groot

Marco R. de Groot is a scholar working on Hematology, Oncology, Genetics, Immunology and Transplantation, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (7 papers), Cancer Cells and Metastasis (5 papers), Renal Transplantation Outcomes and Treatments (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hematology (380 citations), Cancer Research (413 citations), Oncology (693 citations), Hepatology (110 citations) and Transplantation (33 citations). Marco R. de Groot has collaborated with scholars based in Netherlands, France and Belgium. Frequent co-authors include Leon W.M.M. Terstappen, WALTER J.B. MASTBOOM, Arjan G.J. Tibbe, István Vermes, François‐Clément Bidard, Jean‐Yves Pierga, Bas Franken, Job A.M. van der Palen, Florin‐Andrei Taran and Carolyn S. Hall. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, Clinical Infectious Diseases and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Marco R. de Groot

Impact in

Papers in i

In The Last Decade

Marco R. de Groot

Marco R. de Groot's Hit Papers

Peers

Countries citing papers authored by Marco R. de Groot

Fields of papers citing papers by Marco R. de Groot

All Works

About Marco R. de Groot

Explore authors with similar magnitude of impact

Papers in